Article info
Editorial
Angiotensin-converting enzyme inhibitors versus receptor blockers: is one better than the other for cardiovascular prevention?
- Correspondence to Dr Yutaka Furukawa, Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-minamimachi, Chuo-ku, Kobe 650-0047, Japan; furukawa{at}kcho.jp
Citation
Angiotensin-converting enzyme inhibitors versus receptor blockers: is one better than the other for cardiovascular prevention?
Publication history
- First published April 4, 2017.
Online issue publication
August 15, 2017
Article Versions
- Previous version (4 April 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.